SLC16A1 and neoplasm: AZD3965 monotherapy did not result in any toxicity which is possibly due to the fact that both xenograft tumours express high levels of MCT4 (Supplementary Fig. 6) which is a well-known resistance factor to MCT1 inhibition22.